ARTICLE | Company News
PsychoGenics, Sumitomo Dainippon deal
October 12, 2015 7:00 AM UTC
Sumitomo Dainippon’s Sunovion Pharmaceuticals Inc. subsidiary and PsychoGenics extended for four years an August 2007 deal to develop treatments for CNS disorders. The partners have advanced one compo...